Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

As Market Broadens, Look to High Conviction ETF RANK

BY | ETF Database
10/01/2026 | 20 VIEWS
The ETF ecosystem grows with each passing day, as more funds look to embrace the wrapper’s strengths. Perhaps one of the strongest ways to make use of the wrapper, however, is to provide a streamlined way to package high conviction ideas. The Defiance KSM TipRanks Analyst ETF (RANK) provides a solid example of a high conviction ETF.Key Takeaways: While rising rates and costs put up some limits, markets may broaden into quality and value as AI dominates. The high conviction ETF RANK offers flexibility, investing outside of sector limits in other index funds. For example, it has LLY weighted much more than the company is in the S&P 500. RANK charges a 60 basis point fee to track the TipRanks US Momentum Analysts Index. That index looks to package a list of U.S. firms based on analyst buy recommendations and price momentum. Specifically, the high conviction ETF emphasizes firms backed by both analysts and positive market trends. Initially, the index ranks companies by conviction before screening for momentum, initially weighting for market cap. The strategy launched just this past summer, in late June.Where RANK Can Appeal in Today's EnvironmentThat type of approach could have a particularly intriguing use case as the market broadens. Rather than just stick to the biggest indices, a fund like RANK instead looks to deep analysis that is willing to buck the trend. For example, the fund’s third-largest holding, Eli Lilly (LLY), is weighted much more heavily in RANK than in the broader S&P 500. What’s more, it also offers the freedom to invest across categories. Its index looks for the strongest ideas, outside of just tech and the AI revolution. That reduces its contribution to overall concentration risk that comes with the more traditional big index ETFs. What level of market broadening can investors expect in the months to come? See more: Who Are You Calling Passive? Many Index ETFs Dynamically Rebalanced in September While rising costs and rates impact some segments more than others, value opportunities remain. Areas like financials and some health care companies offer value and quality that can bolster a high conviction ETF like RANK. Looking ahead, funds like these represent some of the best use cases from an ever-growing ETF ecosystem. For more news, information, and analysis, visit the Thematic Investing Content Hub. VettaFi LLC (“VettaFi”) is the index provider for RANK for which it receives an index licensing fee. However, RANK is not issued, sponsored, endorsed, or sold by VettaFi, and VettaFi has no obligation or liability in connection with the issuance, administration, marketing, or trading of RANK.

More Commentary

With Nuclear Investing Evolving, Size Up SMRF
BY | ETF Database
10/01/2026 | 34 VIEWS
AMD, Meta Power GAMR's Gaming Index as Capcom Joins
BY | ETF Database
10/01/2026 | 18 VIEWS
More Signs This Defense ETF Can Take Off
BY | ETF Database
10/01/2026 | 23 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.